Antifungal Medication | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
Dosing & Administration | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
FAQs | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
Invasive Aspergillosis | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
CRESEMBA Access & Support | CRESEMBA® (isavuconazonium …
Learn about CRESEMBA Support Solutions℠ for access and reimbursement assistance and find downloadable patient support materials and information. CRESEMBA ® (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows:
Drug Interactions | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
CRESEMBA is a prescription medicine used to treat certain types of fungal infections in the blood or body called invasive aspergillosis and invasive mucormycosis as follows: • CRESEMBA for injection: adults and children 1 year of age and older • CRESEMBA capsules: adults and children 6 years of age and
CRESEMBA® (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: • CRESEMBA for injection: adults and pediatric patients 1 year of age and older • CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
Storage & Handling | CRESEMBA® (isavuconazonium sulfate)
CRESEMBA (isavuconazonium sulfate) is an azole antifungal indicated for the treatment of invasive aspergillosis and invasive mucormycosis as follows: CRESEMBA for injection: adults and pediatric patients 1 year of age and older; CRESEMBA capsules: adults and pediatric patients 6 years of age and older who weigh 16 kg and greater
CRESEMBA is a prescription medicine used to treat people 18 years of age and older with certain types of fungal infections in the blood or body called “aspergillosis,” and “mucormycosis” (zygomycosis).